Mutational status of K-vas and TP53 genes in primary sarcomas of the heart

British Journal of Cancer

Volumn 82, Issue 6, 2000, Pages 1183-1185

  Garcia, J M ^a   Gonzalez, R ^a   Silva, J M ^a   Dominguez, G ^a   Vegazo, I S ^a   Gamallo, C ^b   Provencio, M ^a   Espana P ^a   Bonilla, F ^a,c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Molecular Diagnostic Unit   (Spain)

Author keywords

Cardiac sarcomas; K ras mutations; TP53 mutations

Indexed keywords

DNA; PROTEIN P53;

ADULT; ANGIOSARCOMA; ARTICLE; CLINICAL ARTICLE; EXON; FEMALE; GENE MUTATION; HEART SARCOMA; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR SUPPRESSOR GENE;

EID: 0034009757     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1060     Document Type: Article

References (16)

1. Burke AP, Cowan D and Virmani R (1992) Primary sarcomas of the heart. Cancer 69: 387-395.
2. Crespo MG, Pulpon LA, Pradas G, Serrano S, Segovia J, Vegazo I, Salas C, España P, Silva L and Burgos R (1993) Heart transplantation for cardiac angiosarcoma: should its indication be questioned? J Heart Lung Transplant 12: 527-530
3. Felix CA, Kappel CC, Mitsudomi T, Nau MM, Tsokos M, Crouch GD, Nisen PD, Winick NJ and Helman LJ (1992) Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 52: 2243-2247
4. Hayashi K (1991) PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1: 34-38
5. Kusafuka T, Fukuzawa M, Oue T, Komoto Y, Yoneda A and Okada A (1997) Mutation analysis of p53 gene in childhood malignant solid tumors. J Pediatr Surg 32: 1175-1180
6. McAllister HA and Fenoglio JJ (1978) Tumors of the cardiovascular system. In: Atlas of Tumor Pathology, vol. 15, pp. 73-119. Washington DC: Armed Forces Institute of Pathology
7. Molina JE, Edwards JE and Ward HB (1990) Primary cardiac tumors: experience at the University of Minnesota. J Thorac Cardiovasc Surg 38: 183-191
8. Mulligan LM, Matlashewski GJ, Scrable HJ and Cavenee WK (1990) Mechanism of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87: 5863-5867
9. Naka M, Tomita Y, Nakanishi H, Araki N, Hongyo T, Ochi T and Aozasa K (1997) Mutations of p53 tumor-suppressor gene in angiosarcoma. Int J Cancer 71: 952-955
10. Oto M, Miyake S and Yuasa Y (1993) Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Anal Biochem 213: 19-22
11. Przygodzki RM, Finkelstein SD, Keohavong P, Zhu D, Bakker A, Swalsky PA, Soini Y, Ishak KG and Bennett WP (1997) Sporadic and thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest 76: 153-159
12. Putnam JB, Sweeney MS, Colon R, Lanza LA, Frazier OH and Cooley D (1991) Primary cardiac sarcomas. Ann Thorac Surg 51: 906-910
13. Silverman NA (1980) Primary cardiac tumors. Ann Surg 191: 127-138
14. Stratton MR, Fisher C, Gusterson BA and Cooper CS (1989) Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 49: 6324-6327
15. Wilke W, Maillet M and Robinson R (1993) H-ras-1 point mutations in soft tissue sarcomas. Mod Pathol 6: 129-132
16. Wurl P, Taubert H, Bache M, Kroll J, Meye A, Berger D, Siermann A, Holzhausen HJ, Hinze R, Schmidt H and Rath FW (1996) Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors. Int J Cancer 69: 317-323